Juvenile Neuronal Ceroid Lipofuscinosis
·MeSH: Neuronal Ceroid-Lipofuscinoses
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| plx-200 | Polaryx Therapeutics Inc. (PLYX) |
Frequently asked questions
How many drugs are in development for Juvenile Neuronal Ceroid Lipofuscinosis?
BioSniper tracks 1 drug in development for Juvenile Neuronal Ceroid Lipofuscinosis across 1 company.
How many clinical trials target Juvenile Neuronal Ceroid Lipofuscinosis?
There are 1 clinical trial targeting Juvenile Neuronal Ceroid Lipofuscinosis tracked by BioSniper.
What is the prevalence of Juvenile Neuronal Ceroid Lipofuscinosis?
The estimated prevalence of Juvenile Neuronal Ceroid Lipofuscinosis is approximately 5.0 per 100,000 population.
Deep-dive into Juvenile Neuronal Ceroid Lipofuscinosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis